Market Cap 44.72M
Revenue (ttm) 11.98M
Net Income (ttm) -25.11M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -209.60%
Debt to Equity Ratio 0.00
Volume 46,500
Avg Vol 391,830
Day's Range N/A - N/A
Shares Out 26.31M
Stochastic %K 58%
Beta 0.50
Analysts Hold
Price Target $1.37

Company Profile

LAVA Therapeutics N.V. operates as a clinical-stage immuno-oncology company that focuses on developing cancer treatments. The company through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer patients. Its lead clinical-stage candidates are LAVA-1207 that is in Phase 1/2a clinical trial for metastatic castration-resistant prosta...

Industry: Biotechnology
Sector: Healthcare
Phone: 31 85 016 3100
Address:
Yalelaan 62, Utrecht, Netherlands
TwongStocks
TwongStocks Nov. 13 at 10:18 PM
$LVTX NASDAQ Equity Corporate Actions Alert # 2025 - 611 Information Regarding the Tender Offer of LAVA Therapeutics N.V. (LVTX) https://www.nasdaqtrader.com/TraderNews.aspx?id=eca2025-611 The initial tender offer by $XOMA to acquire all of the outstanding common stock of $LVTX expired one minute after 11:59 p.m. ET, November 12, 2025. A subsequent offering is scheduled to expire one minute after 11:59 p.m. ET, November 20, 2025, unless extended or terminated. The subsequent merger is tentatively scheduled to close prior to the market open on November 21, 2025. In anticipation of the closing, the stock will be halted immediately following the after-hours session at or around 7:50 p.m. on November 20, 2025. If the merger closes as planned, the stock will remain halted on the day of closing (November 21st) and will be suspended effective November 24, 2025. At closing, LVTX shareholders will receive $1.04 and 1 CVR for each share held.
0 · Reply
biochirp
biochirp Nov. 13 at 3:25 PM
$LVTX value of the CVR is climbing that much?
0 · Reply
SimSimBola
SimSimBola Nov. 13 at 1:46 PM
$LVTX bye! $PFE is licking their lips. Back door unlimited access? 😁
0 · Reply
Raxothus
Raxothus Oct. 23 at 8:18 PM
EOD CONTINUATION FOLLOW-UP – 10/22/25 Tracking continuation watchlist from yesterday based on intraday highs vs. close ⚠️ $INDO – Moving sideways, no significant momentum. Neutral. ⚠️ $LVTX – Moving sideways, holding range without breakout. Neutral. ⚠️ $COYA – Moving sideways, low volatility session. Neutral. ✅ $BIOA – Closed 6.08, reached HOD 8.60 (+41%). Strong continuation with heavy range expansion. ✅ $XTKG – Closed 2.04, hit HOD 2.20 (+7.8%). Clean follow-through with steady volume. Recap: 5 total → 2 winners ($BIOA, $XTKG), 0 fails, 3 neutral → 40% accuracy Leaders: $BIOA showed strongest momentum and volume-driven continuation; $XTKG held trend cleanly. Others remain flat awaiting confirmation. #vwap #smallcaps #daytrading #eodfollowup #continuation #snipersetup #accountability
0 · Reply
NoTruceWithTheFuries
NoTruceWithTheFuries Oct. 23 at 5:56 PM
$LVTX Games here
0 · Reply
Bio_Be_Dirty
Bio_Be_Dirty Oct. 22 at 10:10 PM
$LVTX the lava!
0 · Reply
Raxothus
Raxothus Oct. 22 at 8:09 PM
EOD CONTINUATION WATCHLIST – 10/22/25 Focused on stocks that held VWAP and pushed into Power Hour with strength $INDO – 2.1x volume, 1.8% VWAP stretch, micro float (9.5M) 6.4% open-to-current with 7.2% late push, RSI 53.4. Watching breakout > 3.04 for continuation. $LVTX – 2.8x volume, 9.2% VWAP stretch, micro float (5.8M) 11.6% open-to-current with 11.6% late push, RSI 68.3. Watching breakout > 1.64 for continuation. $COYA – 2.8x volume, 0.9% VWAP stretch, small float (12.6M) 7.0% open-to-current with 2.0% late push, RSI 46.0. Watching breakout > 7.55 for continuation. $BIOA – 3.7x volume, 1.0% VWAP stretch, small float (24.3M) 6.2% open-to-current with 0.3% late push, RSI 46.1. Watching breakout > 6.11 for continuation. $XTKG – 6.2x volume, 0.6% VWAP stretch, small float (36.0M) 6.3% open-to-current with 0.5% late push, RSI 41.9. Watching breakout > 2.08 for continuation. #eod #vwap #momentum #smallcaps #daytrading #continuationsetups #powerhourwatch
0 · Reply
MrTicker
MrTicker Oct. 22 at 6:30 PM
$LVTX quick jump in price could indicate afternoon PR, keep an eye on this
0 · Reply
ChartChartist
ChartChartist Oct. 19 at 1:36 AM
$ADVB walk it up with bids $MNTS 1.25 bid $ACDC consolidating $LVTX one more down 🍫 $BCG Top play this week, everyones on it it seems. Get ur trade off.
0 · Reply
MrTicker
MrTicker Oct. 17 at 10:02 PM
$LVTX Form SCHEDULE 13D/A LAVA Therapeutics NV Filed by: Cooperatieve Gilde Healthcare IV U.A. 10K WIZARD 5:01 PM ET 10/17/2025 http://archive.fast-edgar.com/20251017/AI2ZL22EZZ2R6TZ2229V2ZYQINUSZZ22NI72 Filed on: October 17, 2025
0 · Reply
Latest News on LVTX
LAVA Therapeutics Granted Full Waiver for RVO Payment Obligation

Apr 16, 2025, 7:30 AM EDT - 7 months ago

LAVA Therapeutics Granted Full Waiver for RVO Payment Obligation


Analyst Downgrades LAVA Therapeutics, Sees Pipeline Overhang

Feb 28, 2025, 12:32 PM EST - 9 months ago

Analyst Downgrades LAVA Therapeutics, Sees Pipeline Overhang


LAVA Announces Annual Meeting of Shareholders

Jun 10, 2024, 7:00 AM EDT - 1 year ago

LAVA Announces Annual Meeting of Shareholders


LAVA Therapeutics: Assessing A Promising Innovator

Oct 18, 2022, 2:32 AM EDT - 3 years ago

LAVA Therapeutics: Assessing A Promising Innovator


TwongStocks
TwongStocks Nov. 13 at 10:18 PM
$LVTX NASDAQ Equity Corporate Actions Alert # 2025 - 611 Information Regarding the Tender Offer of LAVA Therapeutics N.V. (LVTX) https://www.nasdaqtrader.com/TraderNews.aspx?id=eca2025-611 The initial tender offer by $XOMA to acquire all of the outstanding common stock of $LVTX expired one minute after 11:59 p.m. ET, November 12, 2025. A subsequent offering is scheduled to expire one minute after 11:59 p.m. ET, November 20, 2025, unless extended or terminated. The subsequent merger is tentatively scheduled to close prior to the market open on November 21, 2025. In anticipation of the closing, the stock will be halted immediately following the after-hours session at or around 7:50 p.m. on November 20, 2025. If the merger closes as planned, the stock will remain halted on the day of closing (November 21st) and will be suspended effective November 24, 2025. At closing, LVTX shareholders will receive $1.04 and 1 CVR for each share held.
0 · Reply
biochirp
biochirp Nov. 13 at 3:25 PM
$LVTX value of the CVR is climbing that much?
0 · Reply
SimSimBola
SimSimBola Nov. 13 at 1:46 PM
$LVTX bye! $PFE is licking their lips. Back door unlimited access? 😁
0 · Reply
Raxothus
Raxothus Oct. 23 at 8:18 PM
EOD CONTINUATION FOLLOW-UP – 10/22/25 Tracking continuation watchlist from yesterday based on intraday highs vs. close ⚠️ $INDO – Moving sideways, no significant momentum. Neutral. ⚠️ $LVTX – Moving sideways, holding range without breakout. Neutral. ⚠️ $COYA – Moving sideways, low volatility session. Neutral. ✅ $BIOA – Closed 6.08, reached HOD 8.60 (+41%). Strong continuation with heavy range expansion. ✅ $XTKG – Closed 2.04, hit HOD 2.20 (+7.8%). Clean follow-through with steady volume. Recap: 5 total → 2 winners ($BIOA, $XTKG), 0 fails, 3 neutral → 40% accuracy Leaders: $BIOA showed strongest momentum and volume-driven continuation; $XTKG held trend cleanly. Others remain flat awaiting confirmation. #vwap #smallcaps #daytrading #eodfollowup #continuation #snipersetup #accountability
0 · Reply
NoTruceWithTheFuries
NoTruceWithTheFuries Oct. 23 at 5:56 PM
$LVTX Games here
0 · Reply
Bio_Be_Dirty
Bio_Be_Dirty Oct. 22 at 10:10 PM
$LVTX the lava!
0 · Reply
Raxothus
Raxothus Oct. 22 at 8:09 PM
EOD CONTINUATION WATCHLIST – 10/22/25 Focused on stocks that held VWAP and pushed into Power Hour with strength $INDO – 2.1x volume, 1.8% VWAP stretch, micro float (9.5M) 6.4% open-to-current with 7.2% late push, RSI 53.4. Watching breakout > 3.04 for continuation. $LVTX – 2.8x volume, 9.2% VWAP stretch, micro float (5.8M) 11.6% open-to-current with 11.6% late push, RSI 68.3. Watching breakout > 1.64 for continuation. $COYA – 2.8x volume, 0.9% VWAP stretch, small float (12.6M) 7.0% open-to-current with 2.0% late push, RSI 46.0. Watching breakout > 7.55 for continuation. $BIOA – 3.7x volume, 1.0% VWAP stretch, small float (24.3M) 6.2% open-to-current with 0.3% late push, RSI 46.1. Watching breakout > 6.11 for continuation. $XTKG – 6.2x volume, 0.6% VWAP stretch, small float (36.0M) 6.3% open-to-current with 0.5% late push, RSI 41.9. Watching breakout > 2.08 for continuation. #eod #vwap #momentum #smallcaps #daytrading #continuationsetups #powerhourwatch
0 · Reply
MrTicker
MrTicker Oct. 22 at 6:30 PM
$LVTX quick jump in price could indicate afternoon PR, keep an eye on this
0 · Reply
ChartChartist
ChartChartist Oct. 19 at 1:36 AM
$ADVB walk it up with bids $MNTS 1.25 bid $ACDC consolidating $LVTX one more down 🍫 $BCG Top play this week, everyones on it it seems. Get ur trade off.
0 · Reply
MrTicker
MrTicker Oct. 17 at 10:02 PM
$LVTX Form SCHEDULE 13D/A LAVA Therapeutics NV Filed by: Cooperatieve Gilde Healthcare IV U.A. 10K WIZARD 5:01 PM ET 10/17/2025 http://archive.fast-edgar.com/20251017/AI2ZL22EZZ2R6TZ2229V2ZYQINUSZZ22NI72 Filed on: October 17, 2025
0 · Reply
StocktwitsNews
StocktwitsNews Oct. 17 at 6:45 PM
LAVA Therapeutics Stock Drops After Amended Deal With XOMA Royalty $LVTX $XOMA https://stocktwits.com/news/equity/markets/lava-therapeutics-stock-drops-after-amended-deal-with-xoma-royalty/ch6sjlqR3o3
0 · Reply
MrTicker
MrTicker Oct. 17 at 4:23 PM
$LVTX Form SC TO-T/A LAVA Therapeutics NV Filed by: XOMA Royalty Corp 10K WIZARD 11:22 AM ET 10/17/2025 http://archive.fast-edgar.com/20251017/A62ZU22EZZ2RP2Z222952CYSG62JZZ22NS72 Filed on: October 17, 2025
0 · Reply
MrTicker
MrTicker Oct. 17 at 3:49 PM
$LVTX XOMA and LAVA Therapeutics Announce Amendment To Purchase Agreement; LAVA Shareholders Who Tender Their Shares Will Now Receive An Initial Cash Amount Per Share Of $1.X.04; Amendment To Agreement With LAVA Includes Updated CVR Terms For Tender Offer BENZINGA 10:48 AM ET 10/17/2025
0 · Reply
MrTicker
MrTicker Oct. 14 at 8:38 PM
$LVTX new 13D
0 · Reply
MrTicker
MrTicker Oct. 14 at 8:38 PM
$LVTX Form SCHEDULE 13D/A LAVA Therapeutics NV Filed by: Cooperatieve Gilde Healthcare IV U.A. 10K WIZARD 3:37 PM ET 10/14/2025 http://archive.fast-edgar.com/20251014/AI2ZL22EZW2R62ZZ2R2V22YRINUSZZ22Z872 Filed on: October 14, 2025
0 · Reply
outlawinvestor1
outlawinvestor1 Oct. 12 at 6:43 PM
$LVTX JNJ-89853413 and PF-08046052 both remain active/recruiting as of Oct 2025 updates. https://clinicaltrials.gov/study/NCT06618001?term=JNJ-89853413&rank=1&tab=history&a=14&b=15#version-content-panel https://clinicaltrials.gov/study/NCT05983133?term=PF-08046052%2F%E2%80%8BSGN-EGFRd2&rank=1&tab=history&a=32&b=33#version-content-panel
0 · Reply
biochirp
biochirp Oct. 6 at 6:46 PM
$LVTX I wanted the CVR…better be no deals about to come through
0 · Reply
SweepCastApp
SweepCastApp Oct. 4 at 10:51 AM
$LVTX: Unusual Options Activity Alerted PUT flow observed 75x contracts at Strike price of $5 Exp on 01/16/2026 with Premium of $31K and showing BEARISH Sentiment
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Oct. 3 at 9:58 AM
WATCHLIST OCT 03 2025 $CACI CACI International Wins A Five-Year Contract Valued At More Than $73M To Continue Modernization Of The U.S. Air Force's Integrated Broadcast Service Supporting National Security Efforts Across DOD $CDTX Cidara Secures Up To $339M BARDA Award To Advance CD388 Pandemic Influenza Therapeutic and U.S. Manufacturing $LVTX XOMA Royalty And LAVA Therapeutics Announced The Extension Of The Expiration Of The Tender Offer To Purchase All Outstanding Shares Of Common Shares Of LAVA $GD General Dynamics' Business Unit, General Dynamics Information Technology, Wins $1.25B Enterprise Mission Information Technology Services 2 Task Order To Support U.S. Army Europe and Africa $INTC Intel CEO Lip-Bu Tan Backs $24M Corintis Board As Startup Solves AI's Biggest Bottleneck Problem
0 · Reply
MrTicker
MrTicker Oct. 2 at 8:48 PM
$LVTX XOMA Royalty And LAVA Therapeutics Announced The Extension Of The Expiration Of The Tender Offer To Purchase All Outstanding Shares Of Common Shares Of LAVA BENZINGA 3:47 PM ET 10/2/2025
0 · Reply
MrTicker
MrTicker Oct. 2 at 8:46 PM
$LVTX EMERYVILLE, Calif. and UTRECHT, The Netherlands and PHILADELPHIA, Oct. 02, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation(XOMA) and LAVA Therapeutics N.V.(LVTX) (“LAVA”) today announced the extension of the expiration of the tender offer to purchase all outstanding shares of common shares of LAVA, for (i) a cash amount to be determined in accordance with the Purchase Agreement, plus (ii) a non-transferable contingent value right (“CVR”) per share representing the right to receive 75% of the net proceeds related to LAVA’s two partnered assets and 75% of any net proceeds from any out license or sale of LAVA’s unpartnered programs (the “Offer”). The Offer, which was previously scheduled to expire one minute after 11:59 p.m. Eastern Time on October 3, 2025, has been extended until one minute after 11:59 p.m. Eastern time on October 17, 2025, unless the Offer is further extended or earlier terminated. The proposed acquisition is expected to close in the fourth quarter of 2025,
0 · Reply
MrTicker
MrTicker Oct. 2 at 8:45 PM
$LVTX XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V. GLOBENEWSWIRE 3:43 PM ET 10/2/2025
0 · Reply